Optical Sensors Revolutionize Hemodialysis Safety

Got story updates? Submit your updates here. ›

Researchers from Boston University and Boston Medical Center have developed a compact optical device that combines frequency-domain and broadband continuous-wave near-infrared spectroscopy to continuously monitor tissue hydration levels in dialysis patients. The device provides clinicians with real-time insights into the body's fluid balance, allowing them to adjust treatment before dangerous complications arise. In a pilot study, the optical system outperformed existing blood-based monitoring tools in detecting early signs of fluid imbalance, opening the door to a more responsive and personalized dialysis experience.

Why it matters

Fluid management is a critical challenge in hemodialysis, with nearly half of all patients experiencing complications like sudden drops in blood pressure, cramping, and nausea due to an imbalance between fluid removal and the body's ability to replenish it. Current monitoring tools only provide a partial picture, leaving clinicians to rely on patient symptoms or heuristic rules. This new optical approach offers a more direct window into the underlying physiology, potentially allowing for earlier intervention and improved long-term cardiovascular health.

The details

The researchers created a compact device that combines two forms of near-infrared spectroscopy to measure changes in tissue water content, lipids, and hemoglobin during dialysis. The probe is held against the patient's calf muscle and records continuous optical data throughout the treatment. In a study of 27 adult dialysis patients, the device was able to distinguish between those who experienced complications and those who remained stable. Patients with complications showed little decrease or even slight increases in their tissue water ratio, signaling an emerging mismatch between fluid removal and the body's ability to replenish it. The optical system outperformed existing clinical tools like the Crit-Line hematocrit monitor and blood pressure measurements in detecting these early physiological divergences.

• The pilot study was conducted in 2026.

What’s next

The researchers emphasize that the study was small and the tissue model was simplified, so further validation and development of the optical system is needed before it can be widely adopted in clinical practice.